Posttranscriptional Regulation of PTEN Dosage by Noncoding RNAs

Sci. Signal., 2 November 2010
Vol. 3, Issue 146, p. pe39
DOI: 10.1126/scisignal.3146pe39

Posttranscriptional Regulation of PTEN Dosage by Noncoding RNAs

  1. Lin He*
  1. Division of Cellular and Developmental Biology, Molecular and Cellular Biology Department, University of California at Berkeley, Berkeley, CA 94705, USA.
  1. *Corresponding author. E-mail, lhe{at}berkeley.edu

Abstract

The classic “two-hit” model of tumor-suppressor inactivation, originally established by mathematical modeling of cancer incidence, implies that tumorigenesis requires complete loss of function of tumor-suppressor genes. Although this is true in some tumor types, the exact nature of tumor-suppressor deregulation varies depending on tissue type, stage of cancer development, nature of coexisting molecular lesions, and environmental factors. Emerging evidence has indicated the functional importance of PTEN (phosphatase and tensin homolog) dosage during tumor development. Among the key regulators of PTEN dosage are a number of noncoding RNAs, including microRNAs (miRNAs) and pseudogenes, which regulate PTEN abundance at the posttranscriptional level. Various studies have revealed the essential roles of these PTEN-targeting noncoding RNAs during tumor development, thus providing a paradigm to explore the molecular mechanisms underlying the dosage-dependent effects of key oncogenes and tumor suppressors.

Citation:

L. He, Posttranscriptional Regulation of PTEN Dosage by Noncoding RNAs. Sci. Signal. 3, pe39 (2010).

Comprehensive analysis of PTEN status in Sezary syndrome
C. Cristofoletti, M. C. Picchio, C. Lazzeri, V. Tocco, E. Pagani, A. Bresin, B. Mancini, F. Passarelli, A. Facchiano, E. Scala et al.
Blood 122, 3511-3520 (14 November 2013)

microRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma
C. Liu, J. Iqbal, J. Teruya-Feldstein, Y. Shen, M. J. Dabrowska, K. Dybkaer, M. S. Lim, R. Piva, A. Barreca, E. Pellegrino et al.
Blood 122, 2083-2092 (19 September 2013)

miR-21 is targeted by omega-3 polyunsaturated fatty acid to regulate breast tumor CSF-1 expression
C. C. Mandal, T. Ghosh-Choudhury, N. Dey, G. G. Choudhury, and N. Ghosh-Choudhury
Carcinogenesis 33, 1897-1908 (1 October 2012)

Oncogenic KRAS Regulates miR-200c and miR-221/222 in a 3D-Specific Manner in Colorectal Cancer Cells
T. TSUNODA, Y. TAKASHIMA, Y. YOSHIDA, K. DOI, Y. TANAKA, T. FUJIMOTO, T. MACHIDA, T. OTA, M. KOYANAGI, M. KUROKI et al.
Anticancer Res 31, 2453-2459 (1 July 2011)

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882